Company / Working Capital per Share
GT Biopharma, Inc. Working Capital per Share History
FY2011-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$7.17
FY2020
5-year range
-$25.47 / -$0.05
FY2016-FY2020
Trend
+64.5%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-25.47 to $-7.17 over the past 4 years.
Based on SEC 10-K filings.
-7.17 in FY2020.
Improved from $-25.47 to $-7.17 over the past 4 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, working capital per share increased 64.5% year-over-year.
- Peak working capital per share was recorded in FY2013.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$7.17 | +64.5% |
| FY2017 | -$20.18 | +20.8% |
| FY2016 | -$25.47 | -108.2% |
| FY2015 | -$12.23 | -24114.2% |
| FY2014 | -$0.05 | -304.0% |
| FY2013 | -$0.01 | +47.1% |
| FY2012 | -$0.02 | +31.1% |
| FY2011 | -$0.03 | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026